Online citations, reference lists, and bibliographies.
← Back to Search

Kinetics Of Interaction Of HIV Reverse Transcriptase With Primer/template.

G. Divita, B. Müller, U. Immendörfer, M. Gautel, K. Rittinger, T. Restle, R. Goody
Published 1993 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Intrinsic protein fluorescence of reverse transcriptases from HIV-1 and HIV-2 provides a sensitive signal for monitoring the interaction of the enzymes with primer/template duplex molecules. Kd values for 18/36-mer DNA/DNA duplexes were found to be in the range of a few nanomolar (about 3 times higher for the enzyme from HIV-2 than for that from HIV-1). The quenching of protein fluorescence induced on binding primer/template, together with an increase in extrinsic fluorescence on interaction with primer/template containing a fluorescent nucleotide at the 3'-end of the primer, was used to investigate the kinetics of interaction with reverse transcriptase from HIV-1. The results can be explained in terms of a two-step binding model, with a rapid diffusion-limited initial association (k(ass) = ca. 5 x 10(8) M-1 s-1) followed by a slow isomerization step (k = ca. 0.5 s-1). These (forward) rate constants are increased in the presence of a non-nucleoside inhibitor (S-TIBO) of HIV-1 reverse transcriptase, while the reverse rate constant for the second step is decreased, leading to an increase in affinity between the enzyme and primer/template by a factor of at least 10 when S-TIBO is bound. The results are discussed in terms of present knowledge of the structure of reverse transcriptase.
This paper references
Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase.
K. A. Cohen (1991)
10.1073/PNAS.88.21.9878
Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.
C. K. Shih (1991)
10.1126/SCIENCE.1279806
Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase.
J. Peliska (1992)
Co-expression of the subunits of the heterodimer of HIV-1 reverse transcriptase in Escherichia coli.
B. Müller (1989)
10.1021/BI00229A017
Interaction of fluorescently labeled dideoxynucleotides with HIV-1 reverse transcriptase.
B. Mueller (1991)
10.1073/PNAS.88.15.6863
Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
M. Goldman (1991)
10.1016/0022-2836(92)90117-3
Preferential interaction of human immunodeficiency virus reverse transcriptase with two regions of primer tRNA(Lys) as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotides.
L. Sarih-Cottin (1992)
10.1126/SCIENCE.1701568
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
V. Merluzzi (1990)
10.1002/j.1460-2075.1989.tb08488.x
HIV‐1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA.
C. Barat (1989)
10.1021/BI00222A003
A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.
J. C. Wu (1991)
Mechanism and fidelity of HIV reverse transcriptase.
W. Kati (1992)
10.1073/PNAS.89.20.9652
Reverse transcriptase of human immunodeficiency virus can use either human tRNA(3Lys) or Escherichia coli tRNA(2Gln) as a primer in an in vitro primer-utilization assay.
L. A. Kohlstaedt (1992)
10.1016/0378-1119(92)90686-J
Synthetic human tRNA(UUULys3) and natural bovine tRNA(UUULys3) interact with HIV-1 reverse transcriptase and serve as specific primers for retroviral cDNA synthesis.
S. Weiss (1992)
10.1093/NAR/16.21.9909
A sequence motif in many polymerases.
P. Argos (1988)
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.
V. Sardana (1992)
10.1073/PNAS.83.20.7648
Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes.
M. Johnson (1986)
10.1021/BI00133A013
Human immunodeficiency virus reverse transcriptase: steady-state and pre-steady-state kinetics of nucleotide incorporation.
J. Reardon (1992)
10.1038/343470A0
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
R. Pauwels (1990)
Studies on the mechanism of human immunodeficiency virus reverse transcriptase. Steady-state kinetics, processivity, and polynucleotide inhibition.
C. Majumdar (1988)
10.1126/SCIENCE.1377403
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.
L. A. Kohlstaedt (1992)
Initial binding of 2'-deoxynucleoside 5'-triphosphates to human immunodeficiency virus type 1 reverse transcriptase.
G. Painter (1991)
10.1021/BI00117A045
Identification of the primer binding domain in human immunodeficiency virus reverse transcriptase.
A. Basu (1992)
10.1073/PNAS.89.22.10763
Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities.
V. Gopalakrishnan (1992)
10.1128/JVI.62.7.2525-2529.1988
A single 66-kilodalton polypeptide processed from the human immunodeficiency virus type 2 pol polyprotein in Escherichia coli displays reverse transcriptase activity.
S. L. Le Grice (1988)
10.1073/PNAS.85.4.1218
Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.
A. Hizi (1988)
Kinetic interaction of human immunodeficiency virus type 1 reverse transcriptase with the antiviral tetrahydroimidazo[4,5,1-jk]-[1,4]-benzodiazepine-2-(1H)-thione compound, R82150.
K. Frank (1991)
Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching.
H. Huber (1989)
10.1002/j.1460-2075.1987.tb02623.x
AIDS virus reverse transcriptase defined by high level expression in Escherichia coli.
B. Larder (1987)
10.1089/AID.1992.8.145
Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug.
P. M. Grob (1992)
Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2',3'-dideoxynucleoside 5'-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thion e, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
Z. Debyser (1992)
10.1016/0003-2697(76)90527-3
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
M. M. Bradford (1976)
Expression of the heterodimeric form of human immunodeficiency virus type 2 reverse transcriptase in Escherichia coli and characterization of the enzyme.
B. Mueller (1991)
10.1038/327716A0
Site-specific mutagenesis of AIDS virus reverse transcriptase
B. Larder (1987)
10.1126/SCIENCE.2999980
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.
R. Saiki (1985)
10.1093/NAR/19.4.751
Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNA(Lys,3).
C. Barat (1991)



This paper is referenced by
10.1111/J.1432-1033.1994.TB18798.X
Intrinsic tryptophan fluorescence of bovine liver adenosine kinase, characterization of ligand binding sites and conformational changes.
A. Elalaoui (1994)
10.1074/jbc.272.28.17581
Kinetic Analysis of Four HIV-1 Reverse Transcriptase Enzymes Mutated in the Primer Grip Region of p66
B. Wöhrl (1997)
10.1021/bi801386r
HIV-1 nucleocapsid traps reverse transcriptase on nucleic acid substrates.
Dina Grohmann (2008)
10.1038/nsb0495-303
Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors
R. Esnouf (1995)
10.1074/JBC.270.17.9740
Human Immunodeficiency Virus Type 1 Reverse Transcriptase
M. Jaju (1995)
10.1016/J.JMB.2007.07.044
p66 Trp24 and Phe61 are essential for accurate association of HIV-1 reverse transcriptase with primer/template.
A. Agopian (2007)
10.1515/BCHM3.1996.377.2.71
Cystatins in health and disease.
Y. Henskens (1996)
10.1074/JBC.M001309200
HIV-1 Reverse Transcriptase-Pseudoknot RNA Aptamer Interaction Has a Binding Affinity in the Low Picomolar Range Coupled with High Specificity*
O. Kensch (2000)
10.1093/nar/gkz707
DNA polymerase activity on synthetic N3′→P5′ phosphoramidate DNA templates
V. Lelyveld (2019)
10.1074/jbc.M604460200
Differential Susceptibility of HIV-1 Reverse Transcriptase to Inhibition by RNA Aptamers in Enzymatic Reactions Monitoring Specific Steps during Genome Replication*
Daniel M. Held (2006)
10.1006/BBRC.1997.7770
The interaction of HIV-1 Tat(32-72) with its target RNA: a fluorescence and nuclear magnetic resonance study.
A. Metzger (1997)
10.1021/BI00206A027
Interaction of the reverse transcriptase of human immunodeficiency virus type 1 with DNA.
M. Bakhanashvili (1994)
Impact of nonnucleoside reverse transcriptase (RT) inhibitors on the enzyme-substrate interactions and intramolecular dynamics of wild-type and drug resistant HIV-1 RT
Grant Schauer (2013)
10.1002/PRO.5560050212
Chemical crosslinking of the subunits of HIV‐1 reverse transcriptase
Z. Debyser (1996)
10.1016/B978-012243740-3/50009-0
6 – DNA Polymerases
H. Eun (1996)
10.1016/0958-1669(94)90051-5
Site-directed mutagenesis of HIV reverse transcriptase to probe enzyme processivity and drug binding.
W. Beard (1994)
Refined Model for Primer/Template Binding by HIV-1 Reverse Transcriptase: Pre-steady-state Kinetic Analyses of Primer/Template Binding and Nucleotide Incorporation Events Distinguish Between Different Binding Modes Depending on the Nature of the Nucleic Acid Substrate
Abteilung Physikalische (1999)
10.1074/JBC.274.49.34547
Polypurine Tract Primer Generation and Utilization by Moloney Murine Leukemia Virus Reverse Transcriptase*
S. Schultz (1999)
10.1074/jbc.M802199200
A New Generation of Peptide-based Inhibitors Targeting HIV-1 Reverse Transcriptase Conformational Flexibility*
A. Agopian (2009)
10.1021/BI00016A006
Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase.
P. Patel (1995)
10.1002/PRO.5560030903
Human immunodeficiency virus‐1 reverse transcriptase heterodimer stability
J. Lebowitz (1994)
10.1006/JMBI.1994.0042
Dimerization kinetics of HIV-1 and HIV-2 reverse transcriptase: a two step process.
G. Divita (1995)
10.1006/ABIO.2001.5053
HIV-1 reverse transcriptase interaction with model RNA-DNA duplexes.
I. Gorshkova (2001)
Étude d'une nouvelle classe d'inhibiteurs de la rétrotranscriptase et de l'intégrase du virus de l'immunodéficience humaine de type-1 (VIH-1).
J. Didierjean (2005)
10.1074/jbc.271.21.12213
Role of the "Helix Clamp" in HIV-1 Reverse Transcriptase Catalytic Cycling as Revealed by Alanine-scanning Mutagenesis (*)
W. Beard (1996)
10.1074/jbc.M504481200
Pre-steady-state Kinetic Characterization of the DinB Homologue DNA Polymerase of Sulfolobus solfataricus*
J. Cramer (2005)
10.3390/biom3040889
Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
Grant Schauer (2013)
10.1177/095632029400500403
Synthesis of 2′,3′,5′-trideoxyuridine-5′-methylphosphonic Acid and its Diphosphate Derivative. Study of the Interaction with HIV-1 reverse Transcriptase
S. Benzaria (1994)
10.1093/NAR/25.14.2730
A new peptide vector for efficient delivery of oligonucleotides into mammalian cells.
M. Morris (1997)
10.1128/AAC.00904-07
Mechanisms by Which the G333D Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Facilitates Dual Resistance to Zidovudine and Lamivudine
Shannon Zelina (2007)
Studies in reverse transcriptase: synthesis of inhibitors, conformational analysis, and integration of drug design
T. T. Luu (2000)
10.1016/J.SNB.2006.05.025
Effects of small molecular inhibitors on the binding between HIV-1 reverse transcriptase and DNA as revealed by SPR biosensor
L. Wu (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar